GVHO-Pathway (Netherlands) in Kuwait
How the gvho-pathway (netherlands) pathway operates in Kuwait.
About GVHO-Pathway (Netherlands)
Netherlands' pathway for group or individual compassionate access.
How GVHO-Pathway (Netherlands) works in Kuwait
Kuwait's Ministry of Health operates a Personal Import pathway for specialty drugs not registered locally, typically through a hospital pharmacy with physician attestation.
Patients in Kuwait seeking access under GVHO-Pathway (Netherlands) typically follow this flow: a licensed physician in Kuwait issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Kuwait
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.